![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus...
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a...
BP plc (NYSE:BP) – BP expects weak margins in its refining business to impact its second-quarter profits by up to $700 million. The decline in refining margins, due to excess renewable...
The NEST-IN1 clinical study did not meet its primary or secondary efficacy endpoints, and the company will discontinue further development of HIL-214 in infants The company is exploring the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.17 | 9.60451977401 | 1.77 | 2.07 | 1.76 | 496077 | 1.89682323 | CS |
4 | 0.05 | 2.6455026455 | 1.89 | 2.07 | 1.58 | 581206 | 1.76528608 | CS |
12 | -10.19 | -84.0065952185 | 12.13 | 15.6 | 1.55 | 1163059 | 2.43234207 | CS |
26 | -13.07 | -87.0752831446 | 15.01 | 20.22 | 1.55 | 617593 | 4.15348558 | CS |
52 | -10.57 | -84.4924060751 | 12.51 | 20.22 | 1.55 | 364643 | 5.75489187 | CS |
156 | -16.82 | -89.6588486141 | 18.76 | 24.42 | 1.55 | 211923 | 8.19501871 | CS |
260 | -16.82 | -89.6588486141 | 18.76 | 24.42 | 1.55 | 211923 | 8.19501871 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions